Mira Pharmaceuticals Inc (MIRA)

NASDAQ

$0.92

MIRA Pharmaceuticals, Inc. is a clinical development stage biopharmaceutical company. The company is headquartered in Baltimore, Maryland.

Sector:

Industry:

Target: $17.75 (+1829.35%)

Market Cap

$40M

Free Cash Flow Yield

-10.71%

Beta (5Y)

0.63

Adjust inflation

Log

Valuation

Market Cap$40M

P/B4.09

Profitability

EBITDA-$9.79M

EPS-$0.29

Financial Health

Free Cash Flow Yield-10.71%

Growth & Risk

Beta (5Y)0.63

Sharpe Ratio-0.76